U.S. markets open in 2 hours 49 minutes
  • S&P Futures

    4,448.50
    +2.75 (+0.06%)
     
  • Dow Futures

    34,779.00
    +105.00 (+0.30%)
     
  • Nasdaq Futures

    15,274.75
    -44.00 (-0.29%)
     
  • Russell 2000 Futures

    2,252.90
    +8.90 (+0.40%)
     
  • Crude Oil

    75.04
    +1.06 (+1.43%)
     
  • Gold

    1,748.90
    -2.80 (-0.16%)
     
  • Silver

    22.56
    +0.14 (+0.60%)
     
  • EUR/USD

    1.1707
    -0.0011 (-0.09%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    18.34
    -0.29 (-1.56%)
     
  • GBP/USD

    1.3700
    +0.0019 (+0.14%)
     
  • USD/JPY

    110.9520
    +0.2670 (+0.24%)
     
  • BTC-USD

    43,826.86
    +824.67 (+1.92%)
     
  • CMC Crypto 200

    1,093.05
    -10.01 (-0.91%)
     
  • FTSE 100

    7,067.42
    +15.94 (+0.23%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

SOL Global's HeavenlyRx To Acquire Airganics

HeavenlyRx, a portfolio company of SOL Global Investments Corp (OTC: SOLCF), has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million.

The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.

Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.

All brands are focused to capture the CBD wellness space and already have distribution channels.

Related Links:

Discussing Sol Global's M Hemp Biomass Investment With CEO Brady Cobb

OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.